Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
Rhea-AI Summary
Tactile Medical (Nasdaq: TCMD) said management will participate in the Piper Sandler 37th Annual Healthcare Conference at the Lotte New York Palace in New York, NY from December 2–4, 2025.
The company will take part in a fireside chat on December 2, 2025 at 8:00 a.m. Central Time. A live audio webcast will be available in the Events & Webcasts section of the company investor relations site (http://investors.tactilemedical.com), and an archive will be posted for replay after the conference.
Positive
- None.
Negative
- None.
News Market Reaction 8 Alerts
On the day this news was published, TCMD declined 1.07%, reflecting a mild negative market reaction. Argus tracked a trough of -4.9% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $6M from the company's valuation, bringing the market cap to $545M at that time.
Data tracked by StockTitan Argus on the day of publication.
MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Piper Sandler 37th Annual Healthcare Conference, which is being held at the Lotte New York Palace in New York, NY from December 2nd – 4th. Management will participate in a fireside chat on Tuesday, December 2nd at 8:00 a.m. Central Time.
A live audio webcast of the fireside chat will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com